|
1
|
Zhang HD, Jiang LH, Sun DW, Li J and Ji
ZL: The role of miR-130a in cancer. Breast Cancer. 24:521–527.
2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Gao Y, Feng B, Han S, Lu L, Chen Y, Chu X,
Wang R and Chen L: MicroRNA-129 in human cancers: From
tumorigenesis to clinical treatment. Cell Physiol Biochem.
39:2186–2202. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Cai X, Hagedorn CH and Cullen BR: Human
microRNAs are processed from capped, polyadenylated transcripts
that can also function as mRNAs. RNA. 10:1957–1966. 2004.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Jiang Z, Zhang Y, Chen X, Wu P and Chen D:
Inactivation of the Wnt/β-catenin signaling pathway underlies
inhibitory role of microRNA-129-5p in epithelial-mesenchymal
transition and angiogenesis of prostate cancer by targeting ZIC2.
Cancer Cell Int. 19(271)2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Wang X, Peng L, Gong X, Zhang X and Sun R:
LncRNA HIF1A-AS2 promotes osteosarcoma progression by acting as a
sponge of miR-129-5p. Aging (Albany NY). 11:11803–11813.
2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Obsil T: 14-3-3 proteins-a family of
universal scaffolds and regulators. Semin Cell Dev Biol.
22:661–662. 2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Meng R, Fang J, Yu Y, Hou LK, Chi JR, Chen
AX, Zhao Y and Cao XC: miR-129-5p suppresses breast cancer
proliferation by targeting CBX4. Neoplasma. 65:572–578.
2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yu D, Han GH, Zhao X, Liu X, Xue K, Wang D
and Xu CB: MicroRNA-129-5p suppresses nasopharyngeal carcinoma
lymphangiogenesis and lymph node metastasis by targeting ZIC2. Cell
Oncol (Dordr). 43:249–261. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wang J, Ye C, Liu J and Hu Y: UCA1 confers
paclitaxel resistance to ovarian cancer through miR-129/ABCB1 axis.
Biochem Biophys Res Commun. 501:1034–1040. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wu Q, Meng WY, Jie Y and Zhao H: LncRNA
MALAT1 induces colon cancer development by regulating
miR-129-5p/HMGB1 axis. J Cell Physiol. 233:6750–6757.
2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Xiao N, Zhang J, Chen C, Wan Y, Wang N and
Yang J: miR-129-5p improves cardiac function in rats with chronic
heart failure through targeting HMGB1. Mamm Genome. 30:276–288.
2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hübner A, Jaeschke A and Davis RJ:
Oncogene addiction: Role of signal attenuation. Dev Cell.
11:752–754. 2006.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Yang W and Sun P: Downregulation of
microRNA-129-5p increases the risk of intervertebral disc
degeneration by promoting the apoptosis of nucleus pulposus cells
via targeting BMP2. J Cell Biochem. 120:19684–19690.
2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Patrick E, Rajagopal S, Wong HA, McCabe C,
Xu J, Tang A, Imboywa SH, Schneider JA, Pochet N, Krichevsky AM, et
al: Dissecting the role of non-coding RNAs in the accumulation of
amyloid and tau neuropathologies in Alzheimer's disease. Mol
Neurodegener. 12(51)2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Pahlavani M, Wijayatunga NN, Kalupahana
NS, Ramalingam L, Gunaratne PH, Coarfa C, Rajapakshe K, Kottapalli
P and Moustaid-Moussa N: Transcriptomic and microRNA analyses of
gene networks regulated by eicosapentaenoic acid in brown adipose
tissue of diet-induced obese mice. Biochim Biophys Acta Mol Cell
Biol Lipids. 1863:1523–1531. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Demirsoy IH, Ertural DY, Balci Ş, Çınkır
Ü, Sezer K, Tamer L and Aras N: Profiles of circulating MiRNAs
following metformin treatment in patients with type 2 diabetes. J
Med Biochem. 37:499–506. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Arend RC, Londoño-Joshi AI, Straughn JM Jr
and Buchsbaum DJ: The Wnt/β-catenin pathway in ovarian cancer: A
review. Gynecol Oncol. 131:772–779. 2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Murillo-Garzón V and Kypta R: WNT
signalling in prostate cancer. Nature reviews. Urology. 14:683–696.
2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Tang PM, Zhou S, Meng XM, Wang QM, Li CJ,
Lian GY, Huang XR, Tang YJ, Guan XY, Yan BP, et al: Smad3 promotes
cancer progression by inhibiting E4BP4-mediated NK cell
development. Nat Commun. 8(14677)2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Gao G, Xiu D, Yang B, Sun D, Wei X, Ding
Y, Ma Y and Wang Z: miR-129-5p inhibits prostate cancer
proliferation via targeting ETV1. OncoTargets and Ther.
12:3531–3544. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Jia Y, Gao Y and Dou J: Effects of
miR-129-3p on biological functions of prostate cancer cells through
targeted regulation of Smad3. Oncol Lett. 19:1195–1202.
2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hu Z, Guo J, Zhao M, Jiang T and Yang X:
Predictive values of miR-129 and miR-139 for efficacy on patients
with prostate cancer after chemotherapy and prognostic correlation.
Oncol Lett. 18:6187–6195. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhang RM, Tang T, Yu HM and Yao XD: LncRNA
DLX6-AS1/miR-129-5p/DLK1 axis aggravates stemness of osteosarcoma
through Wnt signaling. Biochem Biophys Res Commun. 507:260–266.
2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chen X, Liu M, Meng F, Sun B, Jin X and
Jia C: The long noncoding RNA HIF1A-AS2 facilitates cisplatin
resistance in bladder cancer. J Cell Biochem. 120:243–252.
2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Lin J, Shi Z, Yu Z and He Z: LncRNA
HIF1A-AS2 positively affects the progression and EMT formation of
colorectal cancer through regulating miR-129-5p and DNMT3A. Biomed
Pharmacother. 98:433–439. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lin H, Zhao Z, Hao Y and He J and He J:
Long noncoding RNA HIF1A-AS2 facilitates cell survival and
migration by sponging miR-33b-5p to modulate SIRT6 expression in
osteosarcoma. Biochem Cell Biol. 98:284–292. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Hou PS, Chuang CY, Kao CF, Chou SJ, Stone
L, Ho HN, Chien CL and Kuo HC: LHX2 regulates the neural
differentiation of human embryonic stem cells via transcriptional
modulation of PAX6 and CER1. Nucleic Acids Res. 41:7753–7770.
2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Tomann P, Paus R, Millar SE, Scheidereit C
and Schmidt-Ullrich R: Lhx2 is a direct NF-κB target gene that
promotes primary hair follicle placode down-growth. Development.
143:1512–1522. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Liang TS, Zheng YJ, Wang J, Zhao JY, Yang
DK and Liu ZS: MicroRNA-506 inhibits tumor growth and metastasis in
nasopharyngeal carcinoma through the inactivation of the
Wnt/β-catenin signaling pathway by down-regulating LHX2. J Exp Clin
Cancer Res. 38(97)2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kuzmanov A, Hopfer U, Marti P,
Meyer-Schaller N, Yilmaz M and Christofori G: LIM-homeobox gene 2
promotes tumor growth and metastasis by inducing autocrine and
paracrine PDGF-B signaling. Mol Oncol. 8:401–416. 2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhou F, Gou S, Xiong J, Wu H, Wang C and
Liu T: Oncogenicity of LHX2 in pancreatic ductal adenocarcinoma.
Mol Biol Rep. 41:8163–8167. 2014.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Song H, Liu J, Wu X, Zhou Y, Chen X, Chen
J, Deng K, Mao C, Huang S and Liu Z: LHX2 promotes malignancy and
inhibits autophagy via mTOR in osteosarcoma and is negatively
regulated by miR-129-5p. Aging (Albany NY). 11:9794–9810.
2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Li G, Xie J and Wang J: Tumor suppressor
function of miR-129-5p in lung cancer. Oncol Lett. 17:5777–5783.
2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Jeong BH, Jin HT, Choi EK, Carp RI and Kim
YS: Lack of association between 14-3-3 beta gene (YWHAB)
polymorphisms and sporadic Creutzfeldt-Jakob disease (CJD). Mol
Biol Rep. 39:10647–10653. 2012.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Xu C, Du Z, Ren S, Liang X and Li H:
MiR-129-5p sensitization of lung cancer cells to etoposide-induced
apoptosis by reducing YWHAB. J Cancer. 11:858–866. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Jacob S, Nayak S, Fernandes G, Barai RS,
Menon S, Chaudhari UK, Kholkute SD and Sachdeva G: Androgen
receptor as a regulator of ZEB2 expression and its implications in
epithelial-to-mesenchymal transition in prostate cancer. Endocr
Relat Cancer. 21:473–486. 2014.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Li X, Li C, Bi H, Bai S, Zhao L, Zhang J
and Qi C: Targeting ZEB2 By microRNA-129 in non-small cell lung
cancer suppresses cell proliferation, invasion and migration via
regulating Wnt/beta-catenin signaling pathway and
epithelial-mesenchymal transition. Onco Targets Ther. 12:9165–9175.
2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Wang X, Li L, Wu Y, Zhang R, Zhang M, Liao
D, Wang G, Qin G, Xu RH and Kang T: CBX4 suppresses metastasis via
recruitment of HDAC3 to the Runx2 promoter in colorectal carcinoma.
Cancer Res. 76:7277–7289. 2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Chaudhary LN, Wilkinson KH and Kong A:
Triple-negative breast cancer: Who should receive neoadjuvant
chemotherapy? Surg Oncol Clin N Am. 27:141–153. 2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Zuo Y, Li Y, Zhou Z, Ma M and Fu K: Long
non-coding RNA MALAT1 promotes proliferation and invasion via
targeting miR-129-5p in triple-negative breast cancer. Biomed
Pharmacother. 95:922–928. 2017.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Del Mastro L and De Laurentiis M: Clinical
applications of trastuzumab in the management of HER-2-positive
breast cancer. Recenti Prog Med. 110:594–603. 2019.PubMed/NCBI View Article : Google Scholar : (In Italian).
|
|
42
|
Lu X, Ma J, Chu J, Shao Q, Zhang Y, Lu G,
Li J, Huang X, Li W, Li Y, et al: MiR-129-5p sensitizes the
response of Her-2 positive breast cancer to trastuzumab by reducing
Rps6. Cell Physiol Biochem. 44:2346–2356. 2017.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Godbole M, Chandrani P, Gardi N, Dhamne H,
Patel K, Yadav N, Gupta S, Badwe R and Dutt A: miR-129-2 mediates
down-regulation of progesterone receptor in response to
progesterone in breast cancer cells. Cancer Biol Ther. 18:801–805.
2017.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Xue J, Zhu X, Huang P, He Y, Xiao Y, Liu R
and Zhao M: Expression of miR-129-5p and miR-433 in the serum of
breast cancer patients and their relationship with
clinicopathological features. Oncol Lett. 20:2771–2778.
2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Zeng H, Wang L, Wang J, Chen T, Li H,
Zhang K, Chen J, Zhen S, Tuluhong D, Li J and Wang S:
microRNA-129-5p suppresses Adriamycin resistance in breast cancer
by targeting SOX2. Arch Biochem Biophys. 651:52–60. 2018.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Yi W, Wang J, Yao Z, Kong Q, Zhang N, Mo
W, Xu L and Li X: The expression status of ZIC2 as a prognostic
marker for nasopharyngeal carcinoma. Int J Clin Exp Pathol.
11:4446–4460. 2018.PubMed/NCBI
|
|
47
|
Matheson CJ, Backos DS and Reigan P:
Targeting WEE1 kinase in cancer. Trends Pharmacol Sci. 37:872–881.
2016.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Zhang H, Lu J, Jiang C and Lu W:
miR-129-1-3p reverses cisplatin resistance of HNE1/CDDP human
nasopharyngeal carcinoma cells by targeting inhibition of WEE1
kinase. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 35:1014–1019.
2019.PubMed/NCBI(In Chinese).
|
|
49
|
Gu LP, Jin S, Xu RC, Zhang J, Geng YC,
Shao XY and Qin LB: Long non-coding RNA PCAT-1 promotes tumor
progression by inhibiting miR-129-5p in human ovarian cancer. Arch
Med Sci. 15:513–521. 2019.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Liu F, Zhao H, Gong L, Yao L, Li Y and
Zhang W: MicroRNA-129-3p functions as a tumor suppressor in serous
ovarian cancer by targeting BZW1. Int J Clin Exp Pathol.
11:5901–5908. 2018.PubMed/NCBI
|
|
51
|
Zhang H and Lu W: LncRNA SNHG12 regulates
gastric cancer progression by acting as a molecular sponge of
miR-320. Mol Med Rep. 17:2743–2749. 2018.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Wang JZ, Xu CL, Wu H and Shen SJ: LncRNA
SNHG12 promotes cell growth and inhibits cell apoptosis in
colorectal cancer cells. Braz J Med Biol Res.
50(e6079)2017.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Sun D and Fan XH: LncRNA SNHG12
accelerates the progression of ovarian cancer via absorbing
miRNA-129 to upregulate SOX4. Eur Rev Med Pharmacol Sci.
23:2345–2352. 2019.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Prensner JR, Iyer MK, Balbin OA,
Dhanasekaran SM, Cao Q, Brenner JC, Laxman B, Asangani IA, Grasso
CS, Kominsky HD, et al: Transcriptome sequencing across a prostate
cancer cohort identifies PCAT-1, an unannotated lincRNA implicated
in disease progression. Nat Biotechnol. 29:742–749. 2011.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Bi M, Yu H, Huang B and Tang C: Long
non-coding RNA PCAT-1 over-expression promotes proliferation and
metastasis in gastric cancer cells through regulating CDKN1A. Gene.
626:337–343. 2017.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Wen J, Xu J, Sun Q, Xing C and Yin W:
Upregulation of long non coding RNA PCAT-1 contributes to cell
proliferation, migration and apoptosis in hepatocellular carcinoma.
Mol Med Rep. 13:4481–4486. 2016.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Qiao L, Liu X, Tang Y, Zhao Z, Zhang J and
Feng Y: Down regulation of the long non-coding RNA PCAT-1 induced
growth arrest and apoptosis of colorectal cancer cells. Life Sci.
188:37–44. 2017.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Wang H, Guan Z, He K, Qian J, Cao J and
Teng L: LncRNA UCA1 in anti-cancer drug resistance. Oncotarget.
8:64638–64650. 2017.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Tan G, Cao X, Dai Q, Zhang B, Huang J,
Xiong S, Zhang Yy, Chen W, Yang J and Li H: A novel role for
microRNA-129-5p in inhibiting ovarian cancer cell proliferation and
survival via direct suppression of transcriptional co-activators
YAP and TAZ. Oncotarget. 6:8676–8686. 2015.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Pronina IV, Loginov VI, Burdennyy AM,
Fridman MV, Kazubskaya TP, Dmitriev AA and Braga EA: Expression and
DNA methylation alterations of seven cancer-associated 3p genes and
their predicted regulator miRNAs (miR-129-2, miR-9-1) in breast and
ovarian cancers. Gene. 576:483–491. 2016.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Kang R, Xie Y, Zhang Q, Hou W, Jiang Q,
Zhu S, Liu J, Zeng D, Wang H, Bartlett DL, et al: Intracellular
HMGB1 as a novel tumor suppressor of pancreatic cancer. Cell Res.
27:916–932. 2017.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Amornsupak K, Jamjuntra P, Warnnissorn M,
O-Charoenrat P, Sa-Nguanraksa D, Thuwajit P, Eccles SA and Thuwajit
C: High ASMA+ fibroblasts and low cytoplasmic
HMGB1+ breast cancer cells predict poor prognosis. Clin
Breast Cancer. 17:441–452.e2. 2017.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Chou YE, Yang PJ, Lin CY, Chen YY, Chiang
WL, Lin PX, Huang ZY, Huang M, Ho YC and Yang SF: The impact of
HMGB1 polymorphisms on prostate cancer progression and
clinicopathological characteristics. Int J Environ Res Public
Health. 17(7247)2020.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Fu R, Yang P, Sajid A and Li Z:
Avenanthramide A induces cellular senescence via
miR-129-3p/Pirh2/p53 signaling pathway to suppress colon cancer
growth. J Agric Food Chem. 67:4808–4816. 2019.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Wu N, Fesler A, Liu H and Ju J:
Development of novel miR-129 mimics with enhanced efficacy to
eliminate chemoresistant colon cancer stem cells. Oncotarget.
9:8887–8897. 2017.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Kang M, Li Y, Liu W, Wang R, Tang A, Hao
H, Liu Z and Ou H: miR-129-2 suppresses proliferation and migration
of esophageal carcinoma cells through downregulation of SOX4
expression. Int J Mol Med. 32:51–58. 2013.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Li Z, Lu J, Zeng G, Pang J, Zheng X, Feng
J and Zhang J: MiR-129-5p inhibits liver cancer growth by targeting
calcium calmodulin-dependent protein kinase IV (CAMK4). Cell Death
Dis. 10(789)2019.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Lu JL, Zhao L, Han SC, Bi JL, Liu HX, Yue
C and Lin L: MiR-129 is involved in the occurrence of uterine
fibroid through inhibiting TET1. Eur Rev Med Pharmacol Sci.
22:4419–4426. 2018.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Wang YF, Yang HY, Shi XQ and Wang Y:
Upregulation of microRNA-129-5p inhibits cell invasion, migration
and tumor angiogenesis by inhibiting ZIC2 via downregulation of the
Hedgehog signaling pathway in cervical cancer. Cancer Biol Ther.
19:1162–1173. 2018.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Lv X, Zhou W, Sun J, Lin R, Ding L, Xu M,
Xu Y, Zhao Z, Chen Y, Bi Y, et al: Visceral adiposity is
significantly associated with type 2 diabetes in middle-aged and
elderly Chinese women: A cross-sectional study. J Diabetes.
9:920–928. 2017.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Hruby A and Hu FB: The epidemiology of
obesity: A big picture. Pharmacoeconomics. 33:673–689.
2015.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Yu YH: Making sense of metabolic obesity
and hedonic obesity. J Diabetes. 9:656–666. 2017.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Ahmed M, Nguyen HQ, Hwang JS, Zada S, Lai
TH, Kang SS and Kim DR: Systematic characterization of
autophagy-related genes during the adipocyte differentiation using
public-access data. Oncotarget. 9:15526–15541. 2018.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Zhang HY, Wang YH, Wang Y, Qu YN, Huang
XH, Yang HX, Zhao CM, He Y, Li SW, Zhou J, et al: miR-129-5p
regulates the immunomodulatory functions of adipose-derived stem
cells via targeting Stat1 signaling. Stem Cells Int.
2019(2631024)2019.PubMed/NCBI View Article : Google Scholar
|
|
75
|
He C and Klionsky DJ: Regulation
mechanisms and signaling pathways of autophagy. Annu Rev Genet.
43:67–93. 2009.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Suryawan A and Hu CY: Effect of serum on
differentiation of porcine adipose stromal-vascular cells in
primary culture. Comp Biochem Physiol Comp Physiol. 105:485–492.
1993.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Harding TM, Hefner-Gravink A, Thumm M and
Klionsky DJ: Genetic and phenotypic overlap between autophagy and
the cytoplasm to vacuole protein targeting pathway. J Biol Chem.
271:17621–17624. 1996.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Ahmed M, Hwang JS, Lai TH, Zada S, Nguyen
HQ, Pham TM, Yun M and Kim DR: Co-expression network analysis of
AMPK and autophagy gene products during adipocyte differentiation.
Int J Mol Sci. 19(1808)2018.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Fu X, Jin L, Han L, Yuan Y, Mu Q, Wang H,
Yang J, Ning G, Zhou D and Zhang Z: miR-129-5p inhibits
adipogenesis through autophagy and may be a potential biomarker for
obesity. Int J Endocrinol. 2019(5069578)2019.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Bielawiec P, Harasim-Symbor E and
Chabowski A: Phytocannabinoids: Useful drugs for the treatment of
obesity? Special focus on cannabidiol. Front Endocrinol (Lausanne).
11(114)2020.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Gracia A, Miranda J, Fernández-Quintela A,
Eseberri I, Garcia-Lacarte M, Milagro FI, Martínez JA, Aguirre L
and Portillo MP: Involvement of miR-539-5p in the inhibition of de
novo lipogenesis induced by resveratrol in white adipose tissue.
Food Funct. 7:1680–1688. 2016.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Dinatolo E, Sciatti E, Anker MS, Lombardi
C, Dasseni N and Metra M: Updates in heart failure: What last year
brought to us. ESC Heart Fail. 5:989–1007. 2018.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Murphy SP, Kakkar R, McCarthy CP and
Januzzi JL Jr: Inflammation in heart failure: JACC state-of-the-art
review. J Am Coll Cardiol. 75:1324–1340. 2020.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Martinotti S, Patrone M and Ranzato E:
Emerging roles for HMGB1 protein in immunity, inflammation, and
cancer. Immunotargets Ther. 4:101–109. 2015.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Volz HC, Laohachewin D, Schellberg D,
Wienbrandt AR, Nelles M, Zugck C, Kaya Z, Katus HA and Andrassy M:
HMGB1 is an independent predictor of death and heart
transplantation in heart failure. Clin Res Cardiol. 101:427–435.
2012.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Gorgulho CM, Romagnoli GG, Bharthi R and
Lotze MT: Johnny on the Spot-chronic inflammation is driven by
HMGB1. Front Immunol. 10(1561)2019.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Piorecka K, Smith D, Kurjata J, Stanczyk M
and Stanczyk WA: Synthetic routes to nanoconjugates of
anthracyclines. Bioorg Chem. 96(103617)2020.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Anakwue R: Cytotoxic-induced heart failure
among breast cancer patients in Nigeria: A call to prevent today's
cancer patients from being tomorrow's cardiac patients. Ann Afr
Med. 19:1–7. 2020.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Bansal N, Adams MJ, Ganatra S, Colan SD,
Aggarwal S, Steiner R, Amdani S, Lipshultz ER and Lipshultz SE:
Strategies to prevent anthracycline-induced cardiotoxicity in
cancer survivors. Cardiooncology. 5(18)2019.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Cai F, Luis MAF, Lin X, Wang M, Cai L, Cen
C and Biskup E: Anthracycline-induced cardiotoxicity in the
chemotherapy treatment of breast cancer: Preventive strategies and
treatment. Mol Clin Oncol. 11:15–23. 2019.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Lim CC, Zuppinger C, Guo X, Kuster GM,
Helmes M, Eppenberger HM, Suter TM, Liao R and Sawyer DB:
Anthracyclines induce calpain-dependent titin proteolysis and
necrosis in cardiomyocytes. J Biol Chem. 279:8290–8299.
2004.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Li Q, Qin M, Tan Q, Li T, Gu Z, Huang P
and Ren L: MicroRNA-129-1-3p protects cardiomyocytes from
pirarubicin-induced apoptosis by down-regulating the
GRIN2D-mediated Ca2+ signalling pathway. J Cell Mol Med.
24:2260–2271. 2020.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Javadov S, Hunter JC, Barreto-Torres G and
Parodi-Rullan R: Targeting the mitochondrial permeability
transition: Cardiac ischemia-reperfusion versus carcinogenesis.
Cell Physiol Biochem. 27:179–190. 2011.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Hajdú T, Juhász T, Szűcs-Somogyi C, Rácz K
and Zákány R: NR1 and NR3B Composed intranuclear
N-methyl-d-aspartate receptor complexes in human melanoma cells.
Int J Mol Sci. 19(1929)2018.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Liu XR, Rempel DL and Gross ML: Composite
conformational changes of signaling proteins upon ligand binding
revealed by a single approach: Calcium-calmodulin study. Anal Chem.
91:12560–12567. 2019.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Hwang HS, Baldo MP, Rodriguez JP, Faggioni
M and Knollmann BC: Efficacy of flecainide in catecholaminergic
polymorphic ventricular tachycardia is mutation-independent but
reduced by calcium overload. Front Physiol. 10(992)2019.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Wei Q, Zhou HY, Shi XD, Cao HY and Qin L:
Long noncoding RNA NEAT1 promotes myocardiocyte apoptosis and
suppresses proliferation through regulation of miR-129-5p. J
Cardiovasc Pharmacol. 74:535–541. 2019.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Camfield P and Camfield C: Regression in
children with epilepsy. Neurosci Biobehav Rev. 96:210–218.
2019.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Devinsky O, Vezzani A, Najjar S, De
Lanerolle NC and Rogawski MA: Glia and epilepsy: Excitability and
inflammation. Trends Neurosci. 36:174–184. 2013.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Fisher RS, Acevedo C, Arzimanoglou A,
Bogacz A, Cross JH, Elger CE, Engel J Jr, Forsgren L, French JA,
Glynn M, et al: ILAE official report: A practical clinical
definition of epilepsy. Epilepsia. 55:475–482. 2014.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Hunsberger JG, Bennett AH, Selvanayagam E,
Duman RS and Newton SS: Gene profiling the response to kainic acid
induced seizures. Brain research. Mol Brain Res. 141:95–112.
2005.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Sharma AK, Searfoss GH, Reams RY, Jordan
WH, Snyder PW, Chiang AY, Jolly RA and Ryan TP: Kainic acid-induced
F-344 rat model of mesial temporal lobe epilepsy: Gene expression
and canonical pathways. Toxicol Pathol. 37:776–789. 2009.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Gorter JA, Iyer A, White I, Colzi A, van
Vliet EA, Sisodiya S and Aronica E: Hippocampal subregion-specific
microRNA expression during epileptogenesis in experimental temporal
lobe epilepsy. Neurobiol Dis. 62:508–520. 2014.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Pernice HF, Schieweck R, Kiebler MA and
Popper B: mTOR and MAPK: From localized translation control to
epilepsy. BMC Neurosci. 17(73)2016.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Wu DM, Zhang YT, Lu J and Zheng YL:
Effects of microRNA-129 and its target gene c-Fos on proliferation
and apoptosis of hippocampal neurons in rats with epilepsy via the
MAPK signaling pathway. J Cell Physiol. 233:6632–6643.
2018.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Rajman M, Metge F, Fiore R, Khudayberdiev
S, Aksoy-Aksel A, Bicker S, Ruedell Reschke C, Raoof R, Brennan GP,
Delanty N, et al: A microRNA-129-5p/Rbfox crosstalk coordinates
homeostatic downscaling of excitatory synapses. EMBO J.
36:1770–1787. 2017.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Siddoway B, Hou H and Xia H: Molecular
mechanisms of homeostatic synaptic downscaling. Neuropharmacology.
78:38–44. 2014.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Wan Y and Yang ZQ: LncRNA NEAT1 affects
inflammatory response by targeting miR-129-5p and regulating Notch
signaling pathway in epilepsy. Cell Cycle. 19:419–431.
2020.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Tuomi T, Santoro N, Caprio S, Cai M, Weng
J and Groop L: The many faces of diabetes: A disease with
increasing heterogeneity. Lancet. 383:1084–1094. 2014.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Hoshino A, Costa-Silva B, Shen TL,
Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di
Giannatale A, Ceder S, et al: Tumour exosome integrins determine
organotropic metastasis. Nature. 527:329–335. 2015.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Melo SA, Luecke LB, Kahlert C, Fernandez
AF, Gammon ST, Kaye J, LeBleu VS, Mittendorf EA, Weitz J, Rahbari
N, et al: Glypican-1 identifies cancer exosomes and detects early
pancreatic cancer. Nature. 523:177–182. 2015.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Fu Q, Jiang H, Wang Z, Wang X, Chen H,
Shen Z, Xiao L, Guo X and Yang T: Injury factors alter miRNAs
profiles of exosomes derived from islets and circulation. Aging
(Albany NY). 10:3986–3999. 2018.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Collinson P: Laboratory medicine is faced
with the evolution of medical practice. J Med Biochem. 36:211–215.
2017.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Wicks K, Torbica T and Mace KA: Myeloid
cell dysfunction and the pathogenesis of the diabetic chronic
wound. Semin Immunol. 26:341–353. 2014.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Williams MD and Nadler JL: Inflammatory
mechanisms of diabetic complications. Curr Diabet Rep. 7:242–248.
2007.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Daigle I and Simon HU: Critical role for
caspases 3 and 8 in neutrophil but not eosinophil apoptosis. Int
Arch Allergy Immuno. 126:147–156. 2001.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Pongracz J, Webb P, Wang K, Deacon E, Lunn
OJ and Lord JM: Spontaneous neutrophil apoptosis involves caspase
3-mediated activation of protein kinase C-delta. J Biol Chem.
274:37329–37334. 1999.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Zhao R, Guan DW, Zhang W, Du Y, Xiong CY,
Zhu BL and Zhang JJ: Increased expressions and activations of
apoptosis-related factors in cell signaling during incised skin
wound healing in mice: A preliminary study for forensic wound age
estimation. Leg Med (Tokyo, Japan). 11 (Suppl 1):S155–S160.
2009.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Willenborg S, Lucas T, van Loo G, Knipper
JA, Krieg T, Haase I, Brachvogel B, Hammerschmidt M, Nagy A,
Ferrara N, et al: CCR2 recruits an inflammatory macrophage
subpopulation critical for angiogenesis in tissue repair. Blood.
120:613–625. 2012.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Devalaraja RM, Nanney LB, Du J, Qian Q, Yu
Y, Devalaraja MN and Richmond A: Delayed wound healing in CXCR2
knockout mice. J Invest Dermatol. 115:234–244. 2000.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Umehara T, Mori R, Mace KA, Murase T, Abe
Y, Yamamoto T and Ikematsu K: Identification of specific miRNAs in
neutrophils of type 2 diabetic mice: Overexpression of
miRNA-129-2-3p accelerates diabetic wound healing. Diabetes.
68:617–630. 2019.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Wang W, Yang C, Wang XY, Zhou LY, Lao GJ,
Liu D, Wang C, Hu MD, Zeng TT, Yan L and Ren M: MicroRNA-129 and
-335 promote diabetic wound healing by inhibiting Sp1-mediated
MMP-9 expression. Diabetes. 67:1627–1638. 2018.PubMed/NCBI View Article : Google Scholar
|
|
123
|
Jobin PG, Butler GS and Overall CM: New
intracellular activities of matrix metalloproteinases shine in the
moonlight. Biochim Biophys Acta Mol Cell Res. 1864:2043–2055.
2017.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Overall CM, Wrana JL and Sodek J:
Transcriptional and post-transcriptional regulation of 72-kDa
gelatinase/type IV collagenase by transforming growth factor-beta 1
in human fibroblasts. Comparisons with collagenase and tissue
inhibitor of matrix metalloproteinase gene expression. J Biol Chem.
266:14064–14071. 1991.PubMed/NCBI
|
|
125
|
McBeth J and Jones K: Epidemiology of
chronic musculoskeletal pain. Best Pract Res Clin Rheumatol.
21:403–425. 2007.PubMed/NCBI View Article : Google Scholar
|
|
126
|
Wieser S, Horisberger B, Schmidhauser S,
Eisenring C, Brügger U, Ruckstuhl A, Dietrich J, Mannion AF,
Elfering A, Tamcan O and Müller U: Cost of low back pain in
Switzerland in 2005. Eur J Health Econ. 12:455–467. 2011.PubMed/NCBI View Article : Google Scholar
|
|
127
|
Dario AB, Ferreira ML, Refshauge KM, Lima
TS, Ordoñana JR and Ferreira PH: The relationship between obesity,
low back pain, and lumbar disc degeneration when genetics and the
environment are considered: A systematic review of twin studies.
Spine J. 15:1106–1117. 2015.PubMed/NCBI View Article : Google Scholar
|
|
128
|
Johnson WE, Eisenstein SM and Roberts S:
Cell cluster formation in degenerate lumbar intervertebral discs is
associated with increased disc cell proliferation. Connect Tissue
Res. 42:197–207. 2001.PubMed/NCBI View Article : Google Scholar
|
|
129
|
Kim KW, Lim TH, Kim JG, Jeong ST, Masuda K
and An HS: The origin of chondrocytes in the nucleus pulposus and
histologic findings associated with the transition of a notochordal
nucleus pulposus to a fibrocartilaginous nucleus pulposus in intact
rabbit intervertebral discs. Spine (Phila Pa 1976). 28:982–990.
2003.PubMed/NCBI View Article : Google Scholar
|
|
130
|
Patterson JE: The pre-travel medical
evaluation: The traveler with chronic illness and the geriatric
traveler. Yale J Biol Med. 65:317–327. 1992.PubMed/NCBI
|
|
131
|
Li J, Yoon ST and Hutton WC: Effect of
bone morphogenetic protein-2 (BMP-2) on matrix production, other
BMPs, and BMP receptors in rat intervertebral disc cells. J Spinal
Disord Tech. 17:423–428. 2004.PubMed/NCBI View Article : Google Scholar
|
|
132
|
Antunovic M, Matic I, Nagy B, Caput
Mihalic K, Skelin J, Stambuk J, Josipovic P, Dzinic T, Paradzik M
and Marijanovic I: FADD-deficient mouse embryonic fibroblasts
undergo RIPK1-dependent apoptosis and autophagy after NB-UVB
irradiation. J Photochem Photobiol B. 194:32–45. 2019.PubMed/NCBI View Article : Google Scholar
|
|
133
|
Wang HQ, Yu XD, Liu ZH, Cheng X, Samartzis
D, Jia LT, Wu SX, Huang J, Chen J and Luo ZJ: Deregulated miR-155
promotes Fas-mediated apoptosis in human intervertebral disc
degeneration by targeting FADD and caspase-3. J Pathol.
225:232–242. 2011.PubMed/NCBI View Article : Google Scholar
|
|
134
|
Li N, Gao Q, Zhou W, Lv X, Yang X and Liu
X: MicroRNA-129-5p affects immune privilege and apoptosis of
nucleus pulposus cells via regulating FADD in intervertebral disc
degeneration. Cell Cycle. 19:933–948. 2020.PubMed/NCBI View Article : Google Scholar
|
|
135
|
Zhao K, Zhang Y, Kang L, Song Y, Wang K,
Li S, Wu X, Hua W, Shao Z, Yang S and Yang C: Methylation of
microRNA-129-5P modulates nucleus pulposus cell autophagy by
targeting Beclin-1 in intervertebral disc degeneration. Oncotarget.
8:86264–86276. 2017.PubMed/NCBI View Article : Google Scholar
|
|
136
|
Maiuri MC, Criollo A, Tasdemir E, Vicencio
JM, Tajeddine N, Hickman JA, Geneste O and Kroemer G: BH3-only
proteins and BH3 mimetics induce autophagy by competitively
disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L).
Autophagy. 3:374–376. 2007.PubMed/NCBI View Article : Google Scholar
|
|
137
|
Pluta R, Ulamek-Koziol M, Januszewski S
and Czuczwar SJ: Gut microbiota and pro/prebiotics in Alzheimer's
disease. Aging (Albany NY). 12:5539–5550. 2020.PubMed/NCBI View Article : Google Scholar
|
|
138
|
Shi Y, Han Y, Niu L, Li J and Chen Y:
MiR-499 inhibited hypoxia/reoxygenation induced cardiomyocytes
injury by targeting SOX6. Biotechnol Lett. 41:837–847.
2019.PubMed/NCBI View Article : Google Scholar
|
|
139
|
Zaletel I, Schwirtlich M, Perović M,
Jovanović M, Stevanović M, Kanazir S and Puškaš N: Early
impairments of hippocampal neurogenesis in 5xFAD mouse model of
Alzheimer's disease are associated with altered expression of SOXB
transcription factors. J Alzheimer's Dis. 65:963–976.
2018.PubMed/NCBI View Article : Google Scholar
|
|
140
|
Zeng Z, Liu Y, Zheng W, Liu L, Yin H,
Zhang S, Bai H, Hua L, Wang S, Wang Z, et al: MicroRNA-129-5p
alleviates nerve injury and inflammatory response of Alzheimer's
disease via downregulating SOX6. Cell Cycle. 18:3095–3110.
2019.PubMed/NCBI View Article : Google Scholar
|
|
141
|
Geng Z, Xu F and Zhang Y:
MiR-129-5p-mediated Beclin-1 suppression inhibits endothelial cell
autophagy in atherosclerosis. Am J Transl Res. 8:1886–1894.
2016.PubMed/NCBI
|
|
142
|
Wan G, An Y, Tao J, Wang Y, Zhou Q, Yang R
and Liang Q: MicroRNA-129-5p alleviates spinal cord injury in mice
via suppressing the apoptosis and inflammatory response through
HMGB1/TLR4/NF-κB pathway. Biosci Rep.
40(BSR20193315)2020.PubMed/NCBI View Article : Google Scholar
|
|
143
|
Huang S, Lv Z, Wen Y, Wei Y, Zhou L, Ke Y,
Zhang Y, Xu Q, Li L, Guo Y, et al: miR-129-2-3p directly targets
SYK gene and associates with the risk of ischaemic stroke in a
Chinese population. J Cell Mol Med. 23:167–176. 2019.PubMed/NCBI View Article : Google Scholar
|
|
144
|
Xu M, Li H, Bai Y, He J, Chen R, An N, Li
Y and Dong Y: miR-129 blocks secondary hyperparathyroidism-inducing
Fgf23/αKlotho signaling in mice with chronic kidney disease. Am J
Med Sci. 361:624–634. 2021.PubMed/NCBI View Article : Google Scholar
|
|
145
|
Zhu Y, Hu Y, Cheng X, Li Q and Niu Q:
Elevated miR-129-5p attenuates hepatic fibrosis through the NF-κB
signaling pathway via PEG3 in a carbon CCl4 rat model. J
Mol Histol. 52:491–501. 2021.PubMed/NCBI View Article : Google Scholar
|
